C. Nakaseko

发表

The Efficacy of Reduced-dose Dasatinib as a Subsequent Therapy in Patients with Chronic Myeloid Leukemia in the Chronic Phase: The LD-CML Study of the Kanto CML Study Group

J. Sakamoto, M. Hino, S. Kimura, 2017, Internal medicine.

Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders

H. Aburatani, S. Sugano, Yutaka Suzuki, 2013, The Journal of experimental medicine.

Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal

N. Minato, J. Bos, S. Yamasaki, 2009, Hematology.

A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.

H. Nakasone, Y. Kanda, Jun Kato, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib-induced neuropathy: Axonal membrane depolarization precedes development of neuropathy

C. Nakaseko, S. Kuwabara, K. Shibuya, 2014, Clinical Neurophysiology.

Long-term treatment with bosutinib in a phase 1/2 study in Japanese chronic myeloid leukemia patients resistant/intolerant to prior tyrosine kinase inhibitor treatment

N. Takahashi, C. Nakaseko, K. Miyamura, 2017, International Journal of Hematology.

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis

C. Nakaseko, N. Mimura, Y. Kawasaki, 2019, Journal of Thrombosis and Thrombolysis.

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

S. Miyano, T. Naoe, Y. Shiraishi, 2017, Blood cancer journal.

Direct activation of STAT5 by ETV6‐LYN fusion protein promotes induction of myeloproliferative neoplasm with myelofibrosis

A. Iwama, L. Hennighausen, K. Yokote, 2011, British journal of haematology.

Identification of a novel TEL–Lyn fusion gene in primary myelofibrosis

A. Iwama, C. Nakaseko, C. Ohwada, 2010, Leukemia.

Analysis of Risk Factors Influencing Development of Renal Failure with Cyclosporin A in Hematopoietic Stem Cell Transplantation Recipients

C. Nakaseko, Hiroyoshi Nakamura, N. Ariyoshi, 2013 .

LR11: a novel biomarker identified in follicular lymphoma

K. Yokote, C. Nakaseko, H. Bujo, 2013, British journal of haematology.

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation.

T. Naoe, N. Emi, N. Iriyama, 2019, Blood advances.

Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia: results of a prospective study in Japan

T. Naoe, T. Nagai, Y. Kanakura, 2010, International journal of hematology.

Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201

T. Naoe, T. Yamane, T. Nagai, 2017, Annals of Hematology.

Air-leak syndrome following allo-SCT in adult patients: report from the Kanto Study Group for Cell Therapy in Japan

C. Nakaseko, H. Sakamaki, S. Okamoto, 2011, Bone Marrow Transplantation.

Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect.

C. Nakaseko, M. Nishimura, E. Sakaida, 2003, Blood.

Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib.

R. Larson, H. Kantarjian, G. Rosti, 2014, Blood.

Super-acute onset of tumor lysis syndrome accompanied by hypercytokinemia during treatment of Hodgkin's lymphoma with ABVD chemotherapy.

C. Nakaseko, M. Nishimura, Hiroyoshi Nakamura, 2010, Clinical therapeutics.

Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML): Japan Adult Leukemia Study Group (JALSG)‐AML206 study

T. Naoe, C. Nakaseko, Y. Miyazaki, 2011, Cancer science.

THREE CASES OF ESOPHAGEAL CARCINOMA AFTER BONE MARROW TRANSPLANTATION

H. Matsubara, C. Nakaseko, Masaya Uesato, 2010 .

Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma

H. Nakasone, Y. Kanda, C. Nakaseko, 2009, American journal of hematology.

Soluble LR11/SorLA represses thermogenesis in adipose tissue and correlates with BMI in humans

Hiroyuki Ebinuma, I. Tatsuno, A. Vidal-Puig, 2015, Nature Communications.

Regulation of Cell Surface Expression of CTLA-4 by Secretion of CTLA-4-Containing Lysosomes Upon Activation of CD4+ T Cells1

T. Fujisawa, Takashi Saito, E. Kominami, 2000, The Journal of Immunology.

Identification of Clonal Immunoglobulin λ Light-Chain Gene Rearrangements in AL Amyloidosis using Next Generation Sequencing.

A. Kaneda, M. Sanada, K. Yokote, 2021, Experimental hematology.

Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells

A. Iwama, K. Yokote, C. Nakaseko, 2020, Haematologica.

Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia

C. Nakaseko, M. Nishimura, C. Ohwada, 2006, Annals of Hematology.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma

H. Asaoku, J. Kuroda, C. Nakaseko, 2018, Hematological oncology.

Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Engagement Delivers an Inhibitory Signal through the Membrane-Proximal Region in the Absence of the Tyrosine Motif in the Cytoplasmic Tail

R. Abe, Takashi Saito, C. Nakaseko, 1999, The Journal of experimental medicine.

Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2.

J. Bonifacino, T. Shiratori, C. Nakaseko, 1997, Immunity.

Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström’s macroglobulinemia and IgM monoclonal gammopathy of undetermined significance

O. Ohara, K. Yokote, K. Matsue, 2017, PloS one.

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

R. Suzuki, T. Kondo, C. Nakaseko, 2016, Leukemia.

Mobilization factors of peripheral blood stem cells in healthy donors.

C. Nakaseko, M. Nishimura, A. Yokota, 2002, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

Multiple angiogenetic factors are upregulated in POEMS syndrome

F. Nomura, C. Nakaseko, M. Mori, 2012, Annals of Hematology.

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

A. Dispenzieri, K. Arimura, C. Nakaseko, 2012, The Cochrane database of systematic reviews.

Identification of a Novel TEL-Lyn Fusion Gene in Chronic Eosinophilic Leukemia with ins (12;8)(p13;q11q21): Effect on Myeloproliferative Transformation and Induction of Myelofibrosis.

A. Iwama, C. Nakaseko, S. Miyagi, 2007 .

Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152).

T. Yamamoto, C. Nakaseko, T. Saito, 1998, Biochemical and biophysical research communications.

Successful Treatment of Rapidly Progressive Life-Threatening Esophageal Submucosal Hematoma in a Patient With van der Hoeve Syndrome

I. Tatsuno, A. Saiki, C. Nakaseko, 2017, Journal of clinical medicine research.

Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation

J. Sakamoto, S. Morita, T. Kumagai, 2017, Cancer science.

Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study

C. Nakaseko, H. Hanaoka, K. Shibuya, 2015, BMJ Open.

Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome

C. Nakaseko, S. Kuwabara, K. Shibuya, 2013, Journal of Neurology, Neurosurgery & Psychiatry.

Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome

C. Nakaseko, S. Kuwabara, K. Kanai, 2009, Bone Marrow Transplantation.

Signalling defect in FMLP‐induced neutrophil respiratory burst in myelodysplastic syndromes

C. Nakaseko, H. Wakita, T. Asai, 1996, British journal of haematology.

Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone‐resistant myeloma cells

C. Nakaseko, M. Nishimura, C. Ohwada, 2007, European journal of haematology.

Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5

M. Kitagawa, C. Morimoto, C. Nakaseko, 2008, Hematology.

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults : the JALSG AML 201 Study

T. Naoe, M. Taniwaki, T. Yamane, 2011 .

Long‐term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study

T. Naoe, T. Nagai, C. Nakaseko, 2012, Cancer science.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy increases carotid intima-media thickness and plaque score with von Willebrand factor activity elevation in patients with malignant lymphoma

I. Tatsuno, A. Saiki, M. Ohira, 2021, Journal of chemotherapy.

Successful treatment with rituximab and donor lymphocyte infusions for fulminant EBV-associated lymphoproliferative disorder that developed 14 years after unrelated BMT

K. Yokote, C. Nakaseko, T. Muto, 2011, Bone Marrow Transplantation.

Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.

A. Iwama, Hiroyuki Ebinuma, K. Yokote, 2012, Clinica chimica acta; international journal of clinical chemistry.

Successful treatment by azacitidine therapy of intestinal Behçet’s disease associated with myelodysplastic syndrome

C. Nakaseko, C. Ohwada, E. Sakaida, 2013, International Journal of Hematology.

Long‐term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia

T. Naoe, T. Yamauchi, C. Nakaseko, 2012, Cancer science.

Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system

T. Naoe, R. Suzuki, M. Kizaki, 2019, International Journal of Hematology.

Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd

Y. Kanda, T. Nagai, M. Kurokawa, 2011, International journal of hematology.

Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment‐free remission

J. Sakamoto, S. Morita, T. Kumagai, 2020, Cancer science.

T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia

C. Nakaseko, N. Mimura, C. Ohwada, 2019, Leukemia & lymphoma.

Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status

C. Nakaseko, C. Ohwada, E. Sakaida, 2014, International Journal of Hematology.

Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation☆

K. Yokote, C. Nakaseko, C. Ohwada, 2013, Leukemia research reports.

Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study

T. Naoe, T. Nagai, C. Nakaseko, 2012, International Journal of Hematology.

Study postremission therapy for acute myeloid leukemia in adults : the JALSG chemotherapy versus 3 courses of high-dose cytarabine alone in A randomized comparison of 4 courses of standard-dose multiagent

T. Naoe, M. Taniwaki, T. Yamane, 2011 .

Outcome of Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Based On Early Molecular Response and Factors Associated with Early Response: 4-Year Follow-up Data From Enestnd (Evaluating Nilotinib Efficacy and Safety in Clinical Trials Newly Diagnosed Patients)

R. Larson, H. Kantarjian, G. Saglio, 2012 .

Acute myeloid leukemia concurrent with spinal epidural extramedullary myeloid sarcoma accompanied by a high CD25 expression and the FLT3-ITD mutation.

K. Yokote, C. Nakaseko, C. Ohwada, 2014, Internal medicine.

Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease

J. Ikeda, C. Nakaseko, T. Muto, 2021, Leukemia research reports.

Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1

A. Iwama, A. Kaneda, T. Tomonaga, 2014, Oncotarget.

Myelodysplastic syndrome with extramedullary erythroid hyperplasia induced by loss of Tet2 in mice

A. Iwama, K. Yokote, C. Nakaseko, 2015, Leukemia & lymphoma.

CD44 and hyaluronan engagement promotes dexamethasone resistance in human myeloma cells

C. Nakaseko, M. Nishimura, C. Ohwada, 2008, European journal of haematology.

Successful treatment with recombinant soluble thrombomodulin of two cases of sinusoidal obstructive syndrome/hepatic veno‐occlusive disease after bone marrow transplantation

K. Yokote, C. Nakaseko, C. Ohwada, 2011, American journal of hematology.

Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis

Y. Kanda, K. Ohashi, C. Nakaseko, 2012 .

Allogeneic hematopoietic stem cell transplantation for primary and secondary myelofibrosis:a retrospective, multicenter study of the Kanto Study Group for Cell Therapy (KSGCT)

Y. Kanda, K. Ohashi, C. Nakaseko, 2012 .

Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma

K. Yokote, K. Matsue, C. Nakaseko, 2014, Leukemia & lymphoma.

Lysosomes Upon Activation of CD4+ T Cells CTLA-4 by Secretion of CTLA-4-Containing Regulation of Cell Surface Expression of

T. Fujisawa, C. Nakaseko, H. Ohno, 2013 .

Upon Activation of CD 4 CTLA-4 by Secretion of CTLA-4-Containing Regulation of Cell Surface Expression of Kominami , Takehiko Fujisawa and

T. Fujisawa, Takashi Saito, E. Kominami, 2000 .

Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation

C. Nakaseko, T. Muto, N. Mimura, 2021, International Journal of Hematology.

Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation.

Y. Kanda, C. Nakaseko, H. Sakamaki, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.

C. Nakaseko, M. Nishimura, Hiroyoshi Nakamura, 2008, Clinical therapeutics.

Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

M. Ogura, K. Tobinai, K. Ishizawa, 2017, Japanese journal of clinical oncology.

Safety , efficacy and pharmacokinetics of humanized anti-CD 52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemia

M. Ogura, K. Tobinai, K. Ishizawa, 2016 .

Leukemic presentation of ALK-negative anaplastic large cell lymphoma in a patient with myelodysplastic syndrome.

K. Ohshima, C. Nakaseko, C. Ohwada, 2012, Internal medicine.

Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy.

C. Nakaseko, S. Kuwabara, S. Ito, 2015, Internal medicine.

Successful control of Epstein–Barr virus (EBV)‐infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection

C. Nakaseko, S. Hara, M. Nishimura, 2004, American journal of hematology.

Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan

N. Tsukada, M. Matsumoto, Kazuhito Suzuki, 2022, EJHaem.

Successful treatment of cytomegalovirus enteritis after unrelated allogeneic stem cell transplantation by the infusion of ex vivo‐expanded CD4+ lymphocytes derived from the recipient's peripheral blood donor cells

T. Morio, C. Nakaseko, T. Muto, 2016, Transplant infectious disease : an official journal of the Transplantation Society.

Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin.

K. Yokote, C. Nakaseko, T. Muto, 2015, Internal medicine.

Safety and efficacy of romiplostim in patients with eltrombopag‐resistant or ‐intolerant immune thrombocytopenia

Masami Takeuchi, C. Nakaseko, K. Inokuchi, 2013, British journal of haematology.

[Chromosomal abnormalities in Castleman's disease with high levels of serum interleukin-6].

C. Nakaseko, M. Nishimura, H. Nakamura, 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan

K. Ohta, M. Matsumoto, K. Ohashi, 2019, International Journal of Hematology.

Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia

C. Nakaseko, T. Muto, N. Mimura, 2015, International Journal of Hematology.

Gradually-Deteriorating Liver Function due to Iron Overload Over Four Years after Allogeneic Stem Cell Transplantation.

C. Nakaseko, N. Mimura, C. Ohwada, 2015, Journal of clinical and experimental hematopathology : JCEH.

Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome

C. Nakaseko, S. Kuwabara, K. Kanai, 2008, Neurology.

Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome

C. Nakaseko, S. Kuwabara, K. Kanai, 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

Autologous peripheral blood stem cell transplantation for POEMS syndrome

C. Nakaseko, S. Kuwabara, K. Kanai, 2006, Neurology.

Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.

Y. Kanda, C. Nakaseko, H. Sakamaki, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ligation of CD44 leads to killing activity in human peripheral mononuclear cells via MAP kinase and tyrosine kinases

C. Nakaseko, M. Nishimura, A. Yokota, 2008, Hematology.

C. Nakaseko, M. Nishimura, C. Ohwada, 2008 .

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study.

T. Naoe, M. Taniwaki, T. Yamane, 2011, Blood.

[Resolution of psoriasis vulgaris following allogeneic bone marrow transplantation for aplastic anemia].

C. Nakaseko, K. Hiruma, M. Nishimura, 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Low-dose trimethoprim–sulfamethoxazole for Pneumocystis jiroveci pneumonia prophylaxis after allogeneic hematopoietic SCT

K. Yokote, C. Nakaseko, T. Muto, 2011, Bone Marrow Transplantation.

Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome.

A. Dispenzieri, K. Arimura, C. Nakaseko, 2012, The Cochrane database of systematic reviews.

Detection of bone lesions by CT in POEMS syndrome.

C. Nakaseko, S. Kuwabara, K. Kanai, 2011, Internal medicine.

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

T. Miyamoto, Y. Hasegawa, C. Nakaseko, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome.

C. Nakaseko, S. Kuwabara, T. Muto, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome

M. Miyazaki, F. Nomura, C. Nakaseko, 2012, Neurology.

Autologous stem cell transplantation for POEMS syndrome.

C. Nakaseko, 2014, Clinical lymphoma, myeloma & leukemia.

Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis.

F. Nomura, C. Nakaseko, S. Kuwabara, 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBT

C. Nakaseko, M. Nishimura, C. Ohwada, 2007, Bone Marrow Transplantation.

Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment

O. Yokosuka, H. Shirasawa, F. Imazeki, 2014, International journal of molecular sciences.

Fasciitis and myositis: an analysis of muscle-related complications caused by chronic GVHD after allo-SCT

C. Nakaseko, H. Sakamaki, S. Okamoto, 2009, Bone Marrow Transplantation.

The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet

C. Nakaseko, T. Muto, N. Mimura, 2017, Internal medicine.

Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B‐cell lymphoma in a Japanese cohort

O. Ohara, A. Kaneda, J. Ikeda, 2021, British journal of haematology.

KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.

A. Iwama, T. Kondo, K. Yokote, 2019, Blood advances.

Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.

A. Iwama, K. Yokote, K. Aoyama, 2016, Leukemia research.

Genetic and transcriptional landscape of plasma cells in POEMS syndrome

O. Ohara, S. Miyano, Y. Shiraishi, 2019, Leukemia.

Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition

A. Iwama, K. Aoyama, C. Nakaseko, 2017, Clinical Cancer Research.

G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow

K. Yokote, W. Schneider, C. Nakaseko, 2014, Annals of Hematology.

Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia

H. Nakasone, Y. Kanda, C. Nakaseko, 2010, Leukemia.

Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome

A. Iwama, A. Kaneda, K. Yokote, 2017, Leukemia.

Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma

C. Nakaseko, T. Muto, N. Mimura, 2018, International Journal of Hematology.

Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia

M. Miyazaki, C. Nakaseko, T. Muto, 2018, Annals of Hematology.

Masami Takeuchi, C. Nakaseko, K. Inokuchi, 2013 .

Identification of Clonal Immunoglobulin λ Light-Chain Gene Rearrangements in AL Amyloidosis Using Next Generation Sequencing

A. Kaneda, K. Yokote, C. Nakaseko, 2019, Blood.

Clonal immunoglobulin λ light‐chain gene rearrangements detected by next generation sequencing in POEMS syndrome

A. Kaneda, K. Yokote, M. Tsuiji, 2018, American journal of hematology.

Allogeneic transplantation for primary myelofibrosis with BM, peripheral blood or umbilical cord blood: an analysis of the JSHCT

T. Naoe, T. Mori, R. Suzuki, 2013, Bone Marrow Transplantation.

A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation

M. Ashizawa, S. Kimura, M. Kikuchi, 2016, Bone Marrow Transplantation.

Prospective multicenter study of single-unit cord blood transplantation with myeloablative conditioning for adult patients with high-risk hematologic malignancies.

Y. Kanda, K. Ohashi, C. Nakaseko, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.

C. Nakaseko, Satoshi Takahashi, T. Kondo, 2015, Blood.

Remarkable donor-derived T cell lymphocytosis before engraftment of a bone marrow transplant for acute lymphoblastic leukemia

C. Nakaseko, N. Mimura, C. Ohwada, 2020, Leukemia & lymphoma.

Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

C. Nakaseko, M. Onizuka, Satoshi Takahashi, 2019, Annals of Hematology.

EFFICACY AND SIGNIFICANCE OF A CONSULTING CLINIC FOR RELATED FAMILY DONORS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION AT THE DEPARTMENT OF TRANSFUSION MEDICINE AND CELL THERAPY

C. Nakaseko, N. Mimura, C. Ohwada, 2017 .

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

T. Naoe, Y. Shiraishi, K. Chiba, 2017, Blood Cancer Journal.

Chronic graft‐versus‐host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program

Y. Kodera, C. Nakaseko, H. Sakamaki, 2007, British journal of haematology.

Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation

Y. Kanda, M. Kurokawa, C. Nakaseko, 2011, International journal of hematology.

Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.

Hiroyuki Ebinuma, C. Nakaseko, H. Bujo, 2014, Clinica chimica acta; international journal of clinical chemistry.

The Soluble Form of LR11 Protein Is a Regulator of Hypoxia-induced, Urokinase-type Plasminogen Activator Receptor (uPAR)-mediated Adhesion of Immature Hematological Cells*

W. Schneider, C. Nakaseko, H. Bujo, 2013, The Journal of Biological Chemistry.

Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus‐6–associated acute limbic encephalitis after unrelated bone marrow transplantation

K. Yokote, C. Nakaseko, C. Ohwada, 2013, Transplant infectious disease : an official journal of the Transplantation Society.

Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy

K. Yokote, C. Nakaseko, T. Muto, 2012, International Journal of Hematology.

Occurrence of lymphoplasmacytic lymphoma 6 years after amelioration of primary cold agglutinin disease by rituximab therapy

C. Nakaseko, Shin-ichiro Hashimoto, Y. Takeda, 2012, International Journal of Hematology.

Two-Year Consolidation By Nilotinib Is Associated with Successful Treatment Free Remission in Chronic Myeloid Leukemia with MR4.5: Subgroup Analysis from STAT2 Trial in Japan

N. Takahashi, C. Nakaseko, H. Wakita, 2016 .

Discontinuation of Dasatinib after Deep Molecular Response for over 2 Years in Patients with Chronic Myelogenous Leukemia and the Unique Profiles of Lymphocyte Subsets for Successful Discontinuation: A Prospective, Multicenter Japanese Trial (D-STOP Trial)

J. Sakamoto, S. Morita, T. Kumagai, 2016 .

Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.

Hiroyuki Ebinuma, K. Yokote, C. Nakaseko, 2016, Clinica chimica acta; international journal of clinical chemistry.

Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.

C. Nakaseko, S. Kuwabara, T. Muto, 2018, Blood.

Secondary solid tumors after allogeneic hematopoietic SCT in Japan

Y. Kanda, C. Nakaseko, H. Sakamaki, 2012, Bone Marrow Transplantation.

Secondary neurolymphomatosis detected by whole-body diffusion-weighted magnetic resonance imaging: a case report.

C. Nakaseko, E. Sakaida, Shin-ichiro Hashimoto, 2013, Journal of clinical and experimental hematopathology : JCEH.

Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia

M. Hino, N. Emi, C. Nakaseko, 2015, Bone Marrow Transplantation.

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia

Y. Kanakura, C. Nakaseko, T. Chou, 2018, International Journal of Hematology.

POEMS syndrome with Guillan–Barré syndrome-like acute onset: a case report and review of neurological progression in 30 cases

C. Nakaseko, S. Kuwabara, K. Kanai, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells

A. Iwama, K. Yokote, C. Nakaseko, 2021, Scientific Reports.

Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma

Y. Kanda, Jun Kato, C. Nakaseko, 2015, Bone Marrow Transplantation.

Long-term complete remission by infusion of ex vivo-expanded donor-derived CD4+ lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation

T. Morio, C. Nakaseko, T. Muto, 2016, Leukemia & lymphoma.

Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line

C. Nakaseko, A. Yokota, M. Onoda, 2009, Hematology.

[Transient nephrotic syndrome after allogeneic bone marrow transplantation for chronic myelogenous leukemia].

Y. Saitoh, C. Nakaseko, S. Hara, 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8

H. Ogawa, K. Ohashi, C. Nakaseko, 2017, Annals of Hematology.

Bone marrow-derived vascular cells in response to injury.

H. Kawamura, K. Yokote, C. Nakaseko, 2003, Journal of atherosclerosis and thrombosis.

Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Mucosa-associated Lymphoid Tissue Lymphoma

I. Tatsuno, C. Nakaseko, N. Hiruta, 2017, Internal medicine.

Molecular remission of multiple myeloma with cytoreductive autografting followed by a dose-reduced allograft

C. Nakaseko, M. Nishimura, C. Ohwada, 2007, Bone Marrow Transplantation.

Successful cord blood transplantation in a minor BCR-ABL+ CML patient who had been in lymphoid blast crisis at presentation

C. Nakaseko, M. Nishimura, C. Ohwada, 2006, Bone Marrow Transplantation.

VII. Hematopoietic Stem Cell Transplantation for Multiple Myeloma

C. Nakaseko, 2016 .

Clinical features of adult-onset chronic active Epstein–Barr virus infection: a retrospective analysis

C. Nakaseko, T. Koyama, O. Miura, 2011, International journal of hematology.

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia

C. Nakaseko, A. Tawada, T. Chiba, 2017, Case Reports in Gastroenterology.

Second cord blood transplantation (CBT) with reduced-intensity conditioning for graft failure after the first CBT for AML

C. Nakaseko, M. Nishimura, C. Ohwada, 2004, Bone Marrow Transplantation.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan

R. Suzuki, M. Ogura, T. Kinoshita, 2014, Haematologica.

A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT

C. Nakaseko, M. Nishimura, A. Yokota, 2002, American journal of hematology.

Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma

Y. Kanda, C. Nakaseko, S. Miyawaki, 2011, Leukemia.

Serum Soluble LR11 As a Novel Biomarker for B Cell Lymphoma

Hiroyuki Ebinuma, K. Yokote, C. Nakaseko, 2011 .

Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis

A. Iwama, M. Sanada, J. Ikeda, 2022, JCI insight.

Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome.

C. Nakaseko, S. Kuwabara, S. Misawa, 2008, Blood.

JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-2. Related disorders of multiple myeloma

S. Iida, C. Nakaseko, M. Abe, 2019, International Journal of Hematology.

Immunomodulator-associated Epstein–Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn’s disease

N. Kato, Y. Nakatani, T. Katsuno, 2019, Clinical journal of gastroenterology.

Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma

K. Yokote, C. Nakaseko, T. Muto, 2015, Leukemia & lymphoma.

Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.

S. Sugano, Yutaka Suzuki, A. Iwama, 2012, Blood.

[A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].

C. Nakaseko, M. Nishimura, A. Ishii, 1994, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report.

I. Sakuma, C. Nakaseko, Shin-ichiro Hashimoto, 2012, Journal of clinical and experimental hematopathology : JCEH.

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial

Y. Kanda, I. Matsumura, C. Nakaseko, 2018, International Journal of Hematology.

Expression of CD56 is an unfavorable prognostic factor for acute promyelocytic leukemia with higher initial white blood cell counts

T. Naoe, T. Yamauchi, N. Emi, 2014, Cancer science.

Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation

Y. Kanda, C. Nakaseko, Satoshi Takahashi, 2012, Annals of Hematology.

Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: A retrospective analysis of JALSG‐APL97

T. Naoe, T. Yamauchi, C. Nakaseko, 2013, Cancer science.

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

S. Miyano, T. Naoe, Y. Shiraishi, 2014, Leukemia.

Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan

K. Mitani, N. Takahashi, S. Tanosaki, 2018, Haematologica.

Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan

K. Mitani, N. Takahashi, C. Nakaseko, 2018, International Journal of Hematology.

myeloid leukemia in chronic phase treated with frontline nilotinib or Early molecular response predicts outcomes in patients with chronic

R. Larson, H. Kantarjian, R. Ribeiro, 2014 .

A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia

M. Taniwaki, N. Takahashi, K. Ishizawa, 2015, International Journal of Hematology.

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease

Y. Furukawa, T. Shibata, A. Iwama, 2023, Leukemia.

Early-Onset Severe Diffuse Alveolar Hemorrhage after Bortezomib Administration Suggestive of Pulmonary Involvement of Myeloma Cells.

K. Yokote, C. Nakaseko, T. Muto, 2015, Journal of clinical and experimental hematopathology : JCEH.

Clonal expansion of non-leukemic cells expressing two novel MLL–ELL variants differing in transforming activity

A. Iwama, C. Nakaseko, M. Nishimura, 2008, Leukemia.

Factors associated with the efficiency of PBSC collection in POEMS syndrome patients undergoing autologous PBSC transplantation

K. Yokote, C. Nakaseko, K. Kanai, 2012, Bone Marrow Transplantation.

Nilotinib Vs. Dasatinib in Achieving MR4.5 for Newly Diagnosed Chronic Myeloid Leukemia: Results of the Prospective Randomized Phase 3 Study, JALSG CML212

T. Naoe, T. Miyamoto, N. Takahashi, 2020 .

Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes

K. Yokote, C. Nakaseko, T. Muto, 2014, Experimental & Molecular Medicine.

Tetraspanin CD 9 modulates ADAM 17-mediated shedding of LR 11 in leukocytes

K. Yokote, C. Nakaseko, T. Muto, 2014 .

Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients

A. Fujikawa, C. Nakaseko, J. Terada, 2021, Journal of clinical medicine.

O. Ohara, K. Yokote, K. Matsue, 2019, PloS one.

[Acute respiratory failure associated with G-CSF-induced leukocyte recovery in three patients with preceding infection].

C. Nakaseko, C. Sakai, T. Takagi, 1997, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Ezh 2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia

S. Sugano, Yutaka Suzuki, A. Iwama, 2012 .

T. Naoe, M. Taniwaki, T. Yamane, 2011, Blood.

Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t(5;10)(q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene

C. Nakaseko, T. Muto, N. Mimura, 2019, Internal medicine.

Successful diagnosis of type II enteropathy-associated T-cell lymphoma using flow cytometry and the cell block technique of celomic fluid manifesting as massive pyoid ascites that could not be diagnosed via emergency laparotomy.

C. Nakaseko, Shin-ichiro Hashimoto, S. Furuya, 2014, Internal medicine.

T. Naoe, M. Taniwaki, T. Yamane, 2011, Blood.

Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5

M. Kitagawa, C. Morimoto, C. Nakaseko, 2008, Hematology.

High presepsin concentrations in bile and its marked elevation in biliary tract diseases: A retrospective analysis.

I. Tatsuno, A. Saiki, M. Ohira, 2021, Clinica chimica acta; international journal of clinical chemistry.

High Concentrations of Presepsin in the Bile and Its Marked Elevation in Biliary Tract Diseases: A Retrospective Analysis

I. Tatsuno, A. Saiki, M. Ohira, 2020 .

Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy

Y. Kanda, Jun Kato, K. Ohashi, 2015, Bone Marrow Transplantation.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan

R. Suzuki, M. Ogura, T. Kinoshita, 2014, Haematologica.

Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia

M. Miyazaki, C. Nakaseko, T. Muto, 2018, Annals of Hematology.

K. Yagasaki, N. Emi, C. Nakaseko, 2022, Japanese Journal of Transplantation and Cellular Therapy.

A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee

S. Iida, C. Nakaseko, H. Naiki, 2023, International journal of hematology.

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia

C. Nakaseko, A. Tawada, T. Chiba, 2017, Case Reports in Gastroenterology.

Restricted Oligo-Clonal Usage of Monoclonal Immunoglobulin λ Light Chain Germline in POEMS Syndrome.

C. Nakaseko, S. Kuwabara, S. Misawa, 2007 .

Successful matched unrelated BMT for secondary AML which developed simultaneously with relapsed Hodgkin's lymphoma

C. Nakaseko, M. Nishimura, C. Ohwada, 2007, Bone Marrow Transplantation.

Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis.

F. Nomura, C. Nakaseko, S. Kuwabara, 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.